Lakeshore Capital Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
8,676
+16
+0.2% +$1.87K 0.83% 39
2026
Q1
$1.04M Buy
8,660
+175
+2% +$20.2K 0.85% 39
2025
Q4
$893K Buy
8,485
+249
+3% +$23.4K 0.71% 40
2025
Q3
$691K Buy
8,236
+96
+1% +$7.91K 0.56% 53
2025
Q2
$644K Buy
8,140
+2,545
+45% +$202K 0.57% 57
2025
Q1
$502K Buy
5,595
+227
+4% +$21.2K 0.48% 62
2024
Q4
$534K Buy
+5,368
New +$553K 0.81% 44

Other funds holding MRK

Lakeshore Capital Group's MRK Position: Q2 2026 in Review

Lakeshore Capital Group increased its Merck (MRK) stake by 0.18% in Q2 2026, buying an estimated $1.87K and bringing the position to 8,676 shares worth $1.11M. The position accounts for 0.83% of the portfolio, ranked #39.

Lakeshore Capital Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lakeshore Capital Group held 8,676 shares of Merck worth $1.11M as of Q2 2026.
  • Lakeshore Capital Group bought 16 Merck shares in Q2 2026, an estimated $1.87K.
  • Merck made up 0.83% of Lakeshore Capital Group's portfolio in Q2 2026, its #39 holding.
  • Lakeshore Capital Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lakeshore Capital Group's 13F filing for Q2 2026, filed 31 Jul 2026.